Wikidata

(Q62054433)

English

Tinostamustine Conditioning and Autologous Stem Cell

clinical trial

In more languages

Statements

short name
TITANIUM1 (English)
0 references
title
Phase 1/2 Open-label Trial of Tinostamustine Conditioning and Autologous Stem Cell Transplantation for Salvage Treatment in Relapsed / Refractory Multiple Myeloma (TITANIUM 1) (English)
0 references
country
Norway
0 references
Switzerland
0 references
start time
19 September 2018
0 references
end time
30 June 2022
0 references
number of participants
71
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62054433&oldid=2149081355"